Biotech Values

[oldberkeley]

What is the downside for insiders if some investors buy shares on account of such inferences? Unless it ends up scuttling a deal—which seems highly unlikely—I don’t see any downside.

Of course there's no downside for the insiders.

However, for an investor who buys based on a faulty inference, the downside might be quite real and quite unpleasant.

I respect your experience and expertise, especially with MNTA, and I genuinely appreciate your thoughts and even your speculations. But this is a tricky one. I'm going to think it over this weekend.